UnitedHealth Group has stepped up its lobbying efforts targeting the Trump administration as it seeks to rebound from numerous lawsuits and regulatory issues that have caused its market value to decline by 40% since April.

This comes after the FTC issued a final rule to promote competition by banning noncompetes nationwide, which has since been challenged in federal court.

One thing a big new batch of Census data shows is where employer plans still have some clout.